{"corpus_id":206965028,"paper_sha":"074885520048af374605b7cd950cb1810f5241b1","doi":"10.1136/gutjnl-2016-312653","arxiv_id":null,"pmid":27789659,"pmcid":"5868296","mag_id":2544680672,"dblp_id":null,"acl_id":null,"title":"Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection","year":2016,"publication_date":"2016-10-27","venue":"Gut","journal":{"name":"Gut","pages":"362 - 371","volume":"67"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":40,"citation_count":164,"influential_citation_count":10,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adenine","mj":false,"qs":[{"q":"analogs & derivatives","mj":false,"ui":"Q000031"},{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D000225"},{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Aged, 80 and over","mj":false,"ui":"D000369"},{"d":"Antiviral Agents","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D000998"},{"d":"Asymptomatic Infections","mj":false,"ui":"D058345"},{"d":"Carcinoma, Hepatocellular","mj":false,"qs":[{"q":"blood","mj":true,"ui":"Q000097"}],"ui":"D006528"},{"d":"Culture Media, Conditioned","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D017077"},{"d":"DNA, Viral","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"}],"ui":"D004279"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Gene Expression","mj":false,"qs":[{"q":"drug effects","mj":false,"ui":"Q000187"}],"ui":"D015870"},{"d":"Genotype","mj":false,"ui":"D005838"},{"d":"Guanine","mj":false,"qs":[{"q":"analogs & derivatives","mj":false,"ui":"Q000031"},{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D006147"},{"d":"HT29 Cells","mj":false,"ui":"D019073"},{"d":"Hep G2 Cells","mj":false,"ui":"D056945"},{"d":"Hepatitis B Surface Antigens","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D006514"},{"d":"Hepatitis B virus","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D006515"},{"d":"Hepatitis B, Chronic","mj":false,"qs":[{"q":"blood","mj":true,"ui":"Q000097"},{"q":"drug therapy","mj":true,"ui":"Q000188"}],"ui":"D019694"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Interferons","mj":false,"ui":"D007372"},{"d":"Interleukins","mj":false,"qs":[{"q":"blood","mj":true,"ui":"Q000097"},{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D007378"},{"d":"Lamivudine","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D019259"},{"d":"Liver Cirrhosis","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"}],"ui":"D008103"},{"d":"Liver Neoplasms","mj":false,"qs":[{"q":"blood","mj":true,"ui":"Q000097"}],"ui":"D008113"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Organophosphonates","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D063065"},{"d":"Polymorphism, Genetic","mj":false,"ui":"D011110"},{"d":"Recombinant Proteins","mj":false,"ui":"D011994"},{"d":"Tenofovir","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D000068698"},{"d":"Up-Regulation","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D015854"},{"d":"Young Adult","mj":false,"ui":"D055815"},{"d":"Interferon Lambda","mj":false,"ui":"D000095022"}],"chemicals":[{"n":"Adenine","ui":"D000225","reg":"JAC85A2161"},{"n":"Antiviral Agents","ui":"D000998","reg":"0"},{"n":"Culture Media, Conditioned","ui":"D017077","reg":"0"},{"n":"DNA, Viral","ui":"D004279","reg":"0"},{"n":"Guanine","ui":"D006147","reg":"5Z93L87A1R"},{"n":"Hepatitis B Surface Antigens","ui":"D006514","reg":"0"},{"n":"Interferons","ui":"D007372","reg":"9008-11-1"},{"n":"Interleukins","ui":"D007378","reg":"0"},{"n":"Lamivudine","ui":"D019259","reg":"2T8Q726O95"},{"n":"Organophosphonates","ui":"D063065","reg":"0"},{"n":"Recombinant Proteins","ui":"D011994","reg":"0"},{"n":"Tenofovir","ui":"D000068698","reg":"99YXE507IL"},{"n":"interferon-lambda, human","ui":"C000624353","reg":"0"},{"n":"Interferon Lambda","ui":"D000095022","reg":"0"},{"n":"entecavir","ui":"C413685","reg":"5968Y6H45M"},{"n":"adefovir","ui":"C053001","reg":"6GQP90I798"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://gut.bmj.com/content/gutjnl/67/2/362.full.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/074885520048af374605b7cd950cb1810f5241b1","s2_open_access_license":"CCBYNC","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Objective The clinical significance of polymorphisms in the interleukin-28B gene encoding interferon (IFN)-λ3, which has antiviral effects, is known in chronic HCV but not in HBV infection. Thus, we measured IFN-λ3 levels in patients with HBV and investigated its clinical significance and association with nucleos(t)ide (NUC) analogue administration. Design Serum IFN-λ3 level was measured in 254 patients with HBV with varying clinical conditions using our own high sensitivity method. The resulting values were compared with various clinical variables. In addition, cell lines originating from various organs were cultured with NUCs, and the production of IFN-λ3 was evaluated. Results Higher serum IFN-λ3 levels were detected in the patients treated with nucleotide analogues (adefovir or tenofovir) compared with those treated with nucleoside analogues (lamivudine or entecavir). There were no other differences in the clinical background between the two groups. A rise in the serum IFN-λ3 levels was observed during additional administration of the nucleotide analogues. In vitro experiments showed that the nucleotide analogues directly and dose-dependently induced IFN-λ3 production only in colon cancer cells. Furthermore, the supernatant from cultured adefovir-treated colon cancer cells significantly induced IFN-stimulated genes (ISGs) and inhibited hepatitis B surface antigen (HBsAg) production in hepatoma cells, as compared with the supernatant from entecavir-treated cells. Conclusions We discovered that the nucleotide analogues show an additional pharmacological effect by inducing IFN-λ3 production, which further induces ISGs and results in a reduction of HBsAg production. These findings provide novel insights for HBV treatment and suggest IFN-λ3 induction as a possible target.","claims":[{"public_id":"cl_29f54d4719279e23d67d650d2abd1bcc","status":"active","text":"Induction of IFN-λ3 by nucleotide analogues represents an additional pharmacological effect and suggests a new potential target for HBV treatment.","confidence":0.8,"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/claims/cl_29f54d4719279e23d67d650d2abd1bcc"},{"public_id":"cl_ef082c20ead7cc5473894dd10ea0823d","status":"active","text":"Nucleotide analogues directly and dose-dependently induce IFN-λ3 production in colon cancer cells in vitro.","confidence":0.95,"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/claims/cl_ef082c20ead7cc5473894dd10ea0823d"},{"public_id":"cl_30432817a6059e9a010e2cfac29d8e9a","status":"active","text":"Patients treated with nucleotide analogues (adefovir or tenofovir) show higher serum IFN-λ3 levels than those treated with nucleoside analogues (lamivudine or entecavir).","confidence":0.95,"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/claims/cl_30432817a6059e9a010e2cfac29d8e9a"},{"public_id":"cl_6d9e563b087fb49fdb3d3deace962040","status":"active","text":"Supernatant from adefovir-treated colon cancer cells induces IFN-stimulated genes (ISGs) and inhibits hepatitis B surface antigen (HBsAg) production in hepatoma cells, compared to supernatant from entecavir-treated cells.","confidence":0.95,"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/claims/cl_6d9e563b087fb49fdb3d3deace962040"}],"concepts":[{"public_id":"co_00d26f490b77d801f77ceb6a1af5787f","status":"active","name":"serum IFN-λ3 level","description":"Measurement of IFN-λ3 concentration in patient serum using a high sensitivity method.","types":["measurement","biomarker"],"aliases":["serum IFN-λ3"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_00d26f490b77d801f77ceb6a1af5787f"},{"public_id":"co_3e8c729de6e9086c7ac77264d8d6f90f","status":"active","name":"hepatitis B surface antigen (HBsAg)","description":"Viral antigen produced by HBV, measured as outcome in hepatoma cells.","types":["viral protein","biomarker"],"aliases":["HBsAg","hepatitis B surface antigen"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_3e8c729de6e9086c7ac77264d8d6f90f"},{"public_id":"co_4cdb47e26ce38028aaace835adc78740","status":"active","name":"HBV infection","description":"Chronic hepatitis B virus infection in the patient population studied.","types":["disease"],"aliases":["hepatitis B virus infection","HBV"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_4cdb47e26ce38028aaace835adc78740"},{"public_id":"co_5466e109c1446f09ff8b0cbedb8bbc4c","status":"active","name":"hepatoma cells","description":"Liver cancer cell line used to measure ISG induction and HBsAg production.","types":["cell line"],"aliases":["hepatoma cell line"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_5466e109c1446f09ff8b0cbedb8bbc4c"},{"public_id":"co_61cdf1483762c6a9945cd14aa99ad221","status":"active","name":"nucleoside analogues","description":"Antiviral drugs lamivudine and entecavir, which did not induce IFN-λ3 in this study.","types":["drug class"],"aliases":["lamivudine","entecavir"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_61cdf1483762c6a9945cd14aa99ad221"},{"public_id":"co_77302d58044a3fc589d0e1ade64b3964","status":"active","name":"nucleotide analogues","description":"Antiviral drugs adefovir and tenofovir, which in this study induce IFN-λ3 production.","types":["drug class"],"aliases":["adefovir","tenofovir"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_77302d58044a3fc589d0e1ade64b3964"},{"public_id":"co_7c238a4a1b01d767b935384b1d02ae64","status":"active","name":"additional pharmacological effect","description":"The non-canonical effect of nucleotide analogues inducing IFN-λ3, beyond their direct antiviral activity.","types":["phenomenon","mechanism"],"aliases":["additional effect","IFN-λ3 induction effect"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_7c238a4a1b01d767b935384b1d02ae64"},{"public_id":"co_7ef10cf158117f9acd5ff91cb79da3fd","status":"active","name":"IFN-stimulated genes (ISGs)","description":"Genes induced by interferon signaling, measured in hepatoma cells after treatment with supernatant from colon cancer cells.","types":["gene set","outcome measure"],"aliases":["ISGs","interferon-stimulated genes"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_7ef10cf158117f9acd5ff91cb79da3fd"},{"public_id":"co_ccfd2420fb7fb91e3707a9b673af4528","status":"active","name":"IFN-λ3","description":"Interferon lambda 3, a cytokine with antiviral effects measured in serum and in vitro in this study.","types":["protein","biomarker"],"aliases":["interferon-λ3","interferon lambda 3"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_ccfd2420fb7fb91e3707a9b673af4528"},{"public_id":"co_dcf8fe968d588fa957a7d7f11ff43dd3","status":"active","name":"colon cancer cells","description":"Cell line derived from colon cancer used for in vitro IFN-λ3 induction experiments.","types":["cell line"],"aliases":["colon cancer cell line"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"url":"https://sah.borca.ai/concepts/co_dcf8fe968d588fa957a7d7f11ff43dd3"}],"external_ids":{"DOI":"10.1136/gutjnl-2016-312653","ArXiv":null,"PubMed":27789659,"PubMedCentral":"5868296","MAG":2544680672,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://gut.bmj.com/content/gutjnl/67/2/362.full.pdf","landing_url":"https://www.semanticscholar.org/paper/074885520048af374605b7cd950cb1810f5241b1","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNC","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":632187,"paper_uid":"4ebab3fe-87f9-4862-a934-0c0367830427","canonical_identity":{"paper_id":632187,"paper_uid":"4ebab3fe-87f9-4862-a934-0c0367830427","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/206965028"}